Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

    • AIDS

    - PMLiVE

    WHO announces priority endemic pathogens for urgent vaccine development

    The study identifies the 17 pathogens that regularly cause diseases in communities

    - PMLiVE

    Valneva and LimmaTech Biologics partner to advance Shigella vaccine candidate

    There is currently no vaccine approved for Shigella, the second leading cause of fatal diarrhoeal disease globally

    - PMLiVE

    WHO announces new mRNA vaccine development initiative against human avian influenza

    H5N1 was responsible for 889 cases and 463 deaths across 23 countries from 2003 to 2024

    - PMLiVE

    GSK and Flagship Pioneering partner in deal worth up to $7bn to discover medicines and vaccines

    The companies aim to develop a portfolio of up to ten candidates

    - PMLiVE

    UKHSA and The Pirbright Institute collaborate to develop vaccines against henipaviruses

    There are currently no licensed vaccines or treatments for the Nipah virus

    - PMLiVE

    AstraZeneca announces plans to invest £650m in UK to boost life sciences sector

    The investment will also help to enhance public health protection and pandemic preparedness in the UK

    - PMLiVE

    New nanoparticle to deliver vaccines and generate strong immune responses at lower dose

    MOF activates the innate immune system through TLRs to provoke strong immune responses

    - PMLiVE

    GSK partners with DNA specialist Elegen to advance medicines and vaccines

    GSK will leverage Elegen’s cell-free synthetic DNA production technology

    - PMLiVE

    New WHO initiative to prioritise endemic pathogens for vaccine development

    Value profiles of 16 pathogens with vaccines in clinical development will be featured

    - PMLiVE

    Moderna and CEPI enter pandemic preparedness partnership

    The partnership aims to expand infectious disease targets for mRNA vaccine technology

    - PMLiVE

    Differences in immune responses could optimise future COVID-19 vaccines

    Vulnerability to different mutations was linked to previous infections and vaccination

    - PMLiVE

    Recognising HIV Vaccine Awareness Day

    HIV Vaccine Awareness Day is on 18 May

    Subscribe to our email news alerts

    Latest content

    Latest intelligence

    Quick links